These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 19128456

  • 1. Inhibition of HIF-1alpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis.
    Nardinocchi L, Puca R, Sacchi A, D'Orazi G.
    Mol Cancer; 2009 Jan 07; 8():1. PubMed ID: 19128456
    [Abstract] [Full Text] [Related]

  • 2. Targeting hypoxia in cancer cells by restoring homeodomain interacting protein-kinase 2 and p53 activity and suppressing HIF-1alpha.
    Nardinocchi L, Puca R, Sacchi A, Rechavi G, Givol D, D'Orazi G.
    PLoS One; 2009 Aug 28; 4(8):e6819. PubMed ID: 19714248
    [Abstract] [Full Text] [Related]

  • 3. HIPK2-a therapeutical target to be (re)activated for tumor suppression: role in p53 activation and HIF-1α inhibition.
    Nardinocchi L, Puca R, Givol D, D'Orazi G.
    Cell Cycle; 2010 Apr 01; 9(7):1270-5. PubMed ID: 20234185
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
    Puca R, Nardinocchi L, Pistritto G, D'Orazi G.
    Gynecol Oncol; 2008 Jun 01; 109(3):403-10. PubMed ID: 18395248
    [Abstract] [Full Text] [Related]

  • 5. HIF-1α antagonizes p53-mediated apoptosis by triggering HIPK2 degradation.
    Nardinocchi L, Puca R, D'Orazi G.
    Aging (Albany NY); 2011 Jan 01; 3(1):33-43. PubMed ID: 21248371
    [Abstract] [Full Text] [Related]

  • 6. HIPK2 suppresses tumor growth and progression of hepatocellular carcinoma through promoting the degradation of HIF-1α.
    Chen P, Duan X, Li X, Li J, Ba Q, Wang H.
    Oncogene; 2020 Apr 01; 39(14):2863-2876. PubMed ID: 32034309
    [Abstract] [Full Text] [Related]

  • 7. Transcriptional regulation of hypoxia-inducible factor 1alpha by HIPK2 suggests a novel mechanism to restrain tumor growth.
    Nardinocchi L, Puca R, Guidolin D, Belloni AS, Bossi G, Michiels C, Sacchi A, Onisto M, D'Orazi G.
    Biochim Biophys Acta; 2009 Feb 01; 1793(2):368-77. PubMed ID: 19046997
    [Abstract] [Full Text] [Related]

  • 8. Hyperglycemia triggers HIPK2 protein degradation.
    Baldari S, Garufi A, Granato M, Cuomo L, Pistritto G, Cirone M, D'Orazi G.
    Oncotarget; 2017 Jan 03; 8(1):1190-1203. PubMed ID: 27901482
    [Abstract] [Full Text] [Related]

  • 9. Anterior gradient 2 is a binding stabilizer of hypoxia inducible factor-1α that enhances CoCl2 -induced doxorubicin resistance in breast cancer cells.
    Li Z, Zhu Q, Hu L, Chen H, Wu Z, Li D.
    Cancer Sci; 2015 Aug 03; 106(8):1041-9. PubMed ID: 26079208
    [Abstract] [Full Text] [Related]

  • 10. Nuclear factor erythroid 2 (NF-E2) p45-related factor 2 interferes with homeodomain-interacting protein kinase 2/p53 activity to impair solid tumors chemosensitivity.
    D'Orazi G, Garufi A, Cirone M.
    IUBMB Life; 2020 Aug 03; 72(8):1634-1639. PubMed ID: 32593231
    [Abstract] [Full Text] [Related]

  • 11. Effects of lentivirus-mediated HIF-1alpha knockdown on hypoxia-related cisplatin resistance and their dependence on p53 status in fibrosarcoma cells.
    Hao J, Song X, Song B, Liu Y, Wei L, Wang X, Yu J.
    Cancer Gene Ther; 2008 Jul 03; 15(7):449-55. PubMed ID: 18421307
    [Abstract] [Full Text] [Related]

  • 12. [Reversal of adriamycin resistance by digoxin in human breast cancer cell line MCF-7/adriamycin and its mechanism].
    Li BH, Yuan L, Shi RR, Wang JG.
    Sheng Li Xue Bao; 2015 Dec 25; 67(6):611-7. PubMed ID: 26701637
    [Abstract] [Full Text] [Related]

  • 13. Involvement of hypoxia-inducible factor-1-alpha in multidrug resistance induced by hypoxia in HepG2 cells.
    Zhu H, Chen XP, Luo SF, Guan J, Zhang WG, Zhang BX.
    J Exp Clin Cancer Res; 2005 Dec 25; 24(4):565-74. PubMed ID: 16471319
    [Abstract] [Full Text] [Related]

  • 14. Hypoxia-induced cytotoxic drug resistance in osteosarcoma is independent of HIF-1Alpha.
    Adamski J, Price A, Dive C, Makin G.
    PLoS One; 2013 Dec 25; 8(6):e65304. PubMed ID: 23785417
    [Abstract] [Full Text] [Related]

  • 15. HIPK2 modulates p53 activity towards pro-apoptotic transcription.
    Puca R, Nardinocchi L, Sacchi A, Rechavi G, Givol D, D'Orazi G.
    Mol Cancer; 2009 Oct 14; 8():85. PubMed ID: 19828042
    [Abstract] [Full Text] [Related]

  • 16. CoCl2 simulated hypoxia induce cell proliferation and alter the expression pattern of hypoxia associated genes involved in angiogenesis and apoptosis.
    Rana NK, Singh P, Koch B.
    Biol Res; 2019 Mar 15; 52(1):12. PubMed ID: 30876462
    [Abstract] [Full Text] [Related]

  • 17. Regulation of vascular endothelial growth factor expression by homeodomain-interacting protein kinase-2.
    Puca R, Nardinocchi L, D'Orazi G.
    J Exp Clin Cancer Res; 2008 Jul 21; 27(1):22. PubMed ID: 18644116
    [Abstract] [Full Text] [Related]

  • 18. Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1alpha.
    Huang L, Ao Q, Zhang Q, Yang X, Xing H, Li F, Chen G, Zhou J, Wang S, Xu G, Meng L, Lu Y, Ma D.
    J Cancer Res Clin Oncol; 2010 Mar 21; 136(3):447-56. PubMed ID: 19760195
    [Abstract] [Full Text] [Related]

  • 19. Hypoxia suppresses chemotherapeutic drug-induced p53 Serine 46 phosphorylation by triggering HIPK2 degradation.
    Moehlenbrink J, Bitomsky N, Hofmann TG.
    Cancer Lett; 2010 Jun 01; 292(1):119-24. PubMed ID: 20018442
    [Abstract] [Full Text] [Related]

  • 20. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
    Li Y, Zhao X, Tang H, Zhong Z, Zhang L, Xu R, Li S, Wang Y.
    Urol Int; 2012 Jun 01; 88(1):95-101. PubMed ID: 22041818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.